← Back to Search

Multifaceted Intervention for Increasing COVID-19 Testing

Phase 2

Recruiting

Led By Marya Gwadz, PhD

Research Sponsored by New York University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18-70 years

In the past month, was employed as a frontline worker in a lower status essential occupation

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12-week fu

Awards & highlights

Study Summary

This trial will test different ways to make it easier for Black and Latino/Hispanic people to get COVID-19 tests, with the goal of reducing the spread of the virus in these communities.

Who is the study for?

This trial is for Black and Latino/Hispanic frontline workers aged 18-70 in lower status essential jobs in NYC. Participants must speak English or Spanish, have a phone for texts, not vaccinated or COVID-tested recently, and haven't had COVID symptoms or treatments like monoclonal antibodies within specific time frames.Check my eligibility

What is being tested?

The study tests four strategies to increase COVID-19 testing: motivational interviews, text messages with quizzes, peer education, and easy test access. The goal is to find the best combination of these methods that can be quickly used widely among frontline workers.See study design

What are the potential side effects?

Since this trial focuses on non-medical interventions like counseling and educational materials rather than drugs or medical procedures, there are no direct physical side effects expected from participation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 70 years old.

Select...

I worked as a frontline worker in an essential job last month.

Select...

I haven't had a COVID-19 vaccine in the last year.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12-week fu

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12-week fu

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-week fu for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

COVID-19 testing

Secondary outcome measures

Attitudes toward COVID-19 vaccination

Confirmatory COVID-19 testing (as needed)

Contact tracing (as needed)

+3 more

Trial Design

16Treatment groups

Experimental Treatment

Group I: Condition 9Experimental Treatment3 Interventions

Component A: motivational interviewing counseling - ON Component B: Text message intervention - ON Component C: Peer education - OFF Component D: Navigation

Group II: Condition 8Experimental Treatment2 Interventions

Component A: motivational interviewing counseling - OFF Component B: Text message intervention - OFF Component C: Peer education - ON Component D: Self-test kit

Group III: Condition 7Experimental Treatment2 Interventions

Component A: motivational interviewing counseling - OFF Component B: Text message intervention - OFF Component C: Peer education - ON Component D: Navigation

Group IV: Condition 6Experimental Treatment3 Interventions

Component A: motivational interviewing counseling - ON Component B: Text message intervention - OFF Component C: Peer education - ON Component D: Self-test kit

Group V: Condition 5Experimental Treatment3 Interventions

Component A: motivational interviewing counseling - ON Component B: Text message intervention - OFF Component C: Peer education - ON Component D: Navigation

Group VI: Condition 4Experimental Treatment3 Interventions

Component A: motivational interviewing counseling - OFF Component B: Text message intervention - ON Component C: Peer education - ON Component D: Self-test kit

Group VII: Condition 3Experimental Treatment3 Interventions

Component A: motivational interviewing counseling - OFF Component B: Text message intervention - ON Component C: Peer education - ON Component D: Navigation

Group VIII: Condition 2Experimental Treatment4 Interventions

Component A: motivational interviewing counseling - ON Component B: Text message intervention - ON Component C: Peer education - ON Component D: Self-test kit

Group IX: Condition 16Experimental Treatment1 Intervention

Component A: motivational interviewing counseling - OFF Component B: Text message intervention - OFF Component C: Peer education - OFF Component D: Self test kit

Group X: Condition 15Experimental Treatment1 Intervention

Component A: motivational interviewing counseling - OFF Component B: Text message intervention - OFF Component C: Peer education - OFF Component D: Navigation

Group XI: Condition 14Experimental Treatment2 Interventions

Component A: motivational interviewing counseling - ON Component B: Text message intervention - OFF Component C: Peer education - OFF Component D: Self test kit

Group XII: Condition 13Experimental Treatment2 Interventions

Component A: motivational interviewing counseling - ON Component B: Text message intervention - OFF Component C: Peer education - OFF Component D: Navigation

Group XIII: Condition 12Experimental Treatment2 Interventions

Component A: motivational interviewing counseling - OFF Component B: Text message intervention - ON Component C: Peer education - OFF Component D: Self test kit

Group XIV: Condition 11Experimental Treatment2 Interventions

Component A: motivational interviewing counseling - OFF Component B: Text message intervention - ON Component C: Peer education - OFF Component D: Navigation

Group XV: Condition 10Experimental Treatment3 Interventions

Component A: motivational interviewing counseling - ON Component B: Text message intervention - ON Component C: Peer education - OFF Component D: Self test kit

Group XVI: Condition 1Experimental Treatment4 Interventions

Component A: motivational interviewing counseling - ON Component B: Text message intervention - ON Component C: Peer education - ON Component D: Navigation

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

New York UniversityLead Sponsor

226 Previous Clinical Trials

313,807 Total Patients Enrolled

Marya Gwadz, PhDPrincipal InvestigatorNew York University

5 Previous Clinical Trials

4,638 Total Patients Enrolled

Media Library

Access to COVID testing Clinical Trial Eligibility Overview. Trial Name: NCT05139927 — Phase 2

COVID-19 Testing Research Study Groups: Condition 13, Condition 12, Condition 16, Condition 4, Condition 7, Condition 1, Condition 2, Condition 3, Condition 6, Condition 10, Condition 8, Condition 14, Condition 15, Condition 9, Condition 11, Condition 5

COVID-19 Testing Clinical Trial 2023: Access to COVID testing Highlights & Side Effects. Trial Name: NCT05139927 — Phase 2

Access to COVID testing 2023 Treatment Timeline for Medical Study. Trial Name: NCT05139927 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this study recruiting patients who are under the age of 55?

"This study is enrolling individuals that are between 18-70 years old."

Answered by AI

Are there any prerequisites to joining this clinical trial?

"This clinical trial is looking for 448 patients, between the ages of 18 and 70, who have received a positive covid-19 test. In addition to this, it is important that participants meet the following criteria: INCLUSION CRITERIA: 1) age 18-70 years; 2) can engage in study activities in English or Spanish; 3) Black or African American (including Caribbean, African, or multi-ethnic Black) and/or Latino or Hispanic race/ethnicity; 4) resides in NYC; 5) in the past month, was employed as a frontline worker in a lower status essential occupation in"

Answered by AI

Has the FDA cleared any COVID-19 tests for public availability?

"Because there is only data supporting the safety of this treatment and no efficacy data, our team has given it a 2."

Answered by AI

What is the total number of participants in this clinical trial?

"Yes, the most recent update on clinicaltrials.gov indicates that this trial is looking for 448 patients at 1 location."

Answered by AI

Is this research study looking for new participants at the moment?

"From what is gathered on clinicaltrials.gov, this study is still in the process of recruiting participants. The trial was originally put up on June 1st of 2022 and was most recently updated on July 15th, 2022."

Answered by AI

Recent research and studies

BMC Public HealthJournal

Using the Multiphase Optimization Strategy (MOST) Framework to Optimize an Intervention to Increase COVID-19 Testing for Black and Latino/hispanic Frontline Essential Workers: A Study Protocol

Gwadz, Marya, Charles M. Cleland, Maria Lizardo, Robert L. Hawkins, Greg Bangser, Lalitha Parameswaran, Victoria Stanhope, et al.. 2022. “Using the Multiphase Optimization Strategy (MOST) Framework to Optimize an Intervention to Increase COVID-19 Testing for Black and Latino/hispanic Frontline Essential Workers: A Study Protocol”. BMC Public Health. Springer Science and Business Media LLC. doi:10.1186/s12889-022-13576-0.

clinicaltrials.govStudy

Using MOST to Optimize an Intervention to Increase COVID-19 Testing for Frontline Essential Workers

2022. "Using MOST to Optimize an Intervention to Increase COVID-19 Testing for Frontline Essential Workers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05139927.